NCT06809686 Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
| NCT ID | NCT06809686 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Richmond Research Institute |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2027-01-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-02-05 with a primary completion date of 2027-01-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
Eligibility Criteria
Inclusion Criteria: 1. Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent. 2. Diagnosed with heart failure. 3. Able and willing to provide informed consent to participate. Exclusion Criteria: 1. Diagnostic test results positive for: 1. HIV-1 or HIV-2 infection 2. Hepatitis B or Hepatitis C infection 2. Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator. 3. Any condition judged by the Investigator to pose an undue risk while participating in the trial 4. Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.
Contact & Investigator
Principal Investigator
PRINCIPAL INVESTIGATOR
Richmond Pharmacology
Frequently Asked Questions
Who can join the NCT06809686 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 80 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06809686 currently recruiting?
Yes, NCT06809686 is actively recruiting participants. Contact the research team at volunteer@richmondpharmacology.com for enrollment information.
Where is the NCT06809686 trial being conducted?
This trial is being conducted at London, United Kingdom, London, United Kingdom.
Who is sponsoring the NCT06809686 clinical trial?
NCT06809686 is sponsored by Richmond Research Institute. The principal investigator is Principal Investigator at Richmond Pharmacology. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.